The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries. - Wikidata - wikimedia - TriplyDB

The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.

The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.

http://www.wikidata.org/entity/Q37420729

about

The endocannabinoid system: 'NO' longer anonymous in the control of nitrergic signalling?The endocannabinoid system in cardiovascular function: novel insights and clinical implications.Endocannabinoids modulate Gq/11 protein-coupled receptor agonist-induced vasoconstriction via a negative feedback mechanism.EFFECT OF MATERNAL HIGH-FAT DIET ON KEY COMPONENTS OF THE PLACENTAL AND HEPATIC ENDOCANNABINOID SYSTEM.Activation of CB1 receptors by 2-arachidonoylglycerol attenuates vasoconstriction induced by U46619 and angiotensin II in human and rat pulmonary arteries.Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism.Anandamide and endocannabinoid system: an attractive therapeutic approach for cardiovascular disease.

P2860

Q33712156-4E3C4EED-B818-4594-9B62-40472E8B7B3B Q46204521-48DA6841-6A57-4B7F-9715-70741C36F983 Q47392882-1D25F09C-8EBA-4603-B351-E61C8026B843 Q47402428-CB5D7A26-BAE7-447C-AF98-DFA7128FA717 Q51081657-AC7E0683-2DF1-4C5C-8244-3ABCB2B41644 Q55471337-45A59428-ADB5-463C-BD11-BD02F43C628F Q55487760-9817E5EF-0BAD-43E1-BF1F-36A392DDAEE9

P2860

The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.

http://www.wikidata.org/entity/Q37420729

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The endocannabinoid anandamide ...... in human mesenteric arteries.

@en

The endocannabinoid anandamide ...... in human mesenteric arteries.

@nl

type

label

The endocannabinoid anandamide ...... in human mesenteric arteries.

@en

The endocannabinoid anandamide ...... in human mesenteric arteries.

@nl

prefLabel

The endocannabinoid anandamide ...... in human mesenteric arteries.

@en

The endocannabinoid anandamide ...... in human mesenteric arteries.

@nl

P1433

Q37420729-62EF8D80-D69F-415C-8093-C178AB013057

P1476

Q37420729-EC9073A6-9CD7-415D-B808-7F9EE875A10F

P2093

Q37420729-78F3D6D1-A2D7-4EC1-A902-66CFECC14964

Q37420729-C7040A01-F03F-4213-85BF-47693513215B

P2860

Q37420729-0D9FF991-62F1-4BB7-B067-0045DE2BE038

Q37420729-15FFB4C5-F555-44A3-BE4D-57B111EF8DD8

Q37420729-1D1039C8-5001-4308-A350-713FC56E62CC

Q37420729-2776F970-CB00-4FA5-AF7A-0BF4F7F13239

Q37420729-2B703F10-34E9-4B7E-9767-95670E5C7FF6

Q37420729-349EE118-B02C-4297-8F7F-26D961023DE9

Q37420729-397F122B-BF84-4526-A706-11264E87D718

Q37420729-3B5AEBD9-35BE-4E09-B5F2-7713FB9DB091

Q37420729-3C79B39F-0D2B-476F-AA55-3CD48D1A4FEE

Q37420729-4E274D61-970C-4144-B725-32A7075713DA

P304

Q37420729-5127C44C-631C-4D82-858B-7B2971C513E2

P31

Q37420729-A69D2BE5-007C-41A5-B498-2C505776EC14

P356

Q37420729-7FF7EB59-3540-490F-B24D-CFA58ADAE915

P433

Q37420729-28F4353F-5DDB-43E0-B8F6-38699012C488

P478

Q37420729-F5F6D247-975C-4054-A777-F03617749CA4

P50

Q37420729-5159F3A5-AF77-4056-B870-9AC4CDF2D125

Q37420729-8B34DC67-2444-4781-AF96-D4DA30652B43

P577

Q37420729-D8FB181E-150D-4842-A51E-C02857FBEF7F

P698

Q37420729-03599770-5786-4017-B88A-3D0A44F4A43A

P921

Q37420729-1789CB91-B54D-4780-B32F-928F88FA93A0

Q37420729-9F009D0A-0D6D-49D1-8EE6-3081259B3E06

Q37420729-AFA7AB35-9F49-4067-A7F1-F50FB2562EEF

Q37420729-D65A854D-41AB-44A0-A371-7D933A05CFE4

P932

Q37420729-6CE8EB4D-ABA6-43A4-8378-7FB8CE411CB2

P356

J.PHRS.2016.08.028

P1433

Pharmacological Research

P1476

The endocannabinoid anandamide ...... in human mesenteric arteries.

@en

P2093

Christopher P Stanley

http://www.w3.org/2001/XMLSchema#string

William H Hind

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

Activation of the peripheral endocannabinoid system in human obesity

Vascular targets for cannabinoids: animal and human studies

Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells

Time-dependent vascular effects of Endocannabinoids mediated by peroxisome proliferator-activated receptor gamma (PPARγ)

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain

Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol

Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.

Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.

P304

356-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PHRS.2016.08.028

http://www.w3.org/2001/XMLSchema#string

P433

Pt A

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Saoirse E O'Sullivan

Cristina Tufarelli

P577

2016-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27633407

http://www.w3.org/2001/XMLSchema#string

P921

endocannabinoids

P932

5113919

http://www.w3.org/2001/XMLSchema#string